# 机械循环支持装置市场

> 机械循环支持装置市场研究报告按类型（主动脉内球囊泵、心室辅助装置、全人工心脏、体外膜氧合）、按应用（心脏手术、心力衰竭管理、心肌梗死、心源性休克）、按最终用途（医院、门诊手术中心、居家护理）、按操作模式（植入式装置、体外装置）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.97%
- **2024:** $ 3.8 Billion
- **2025:** $ 4.1 Billion
- **2035:** $ 8.84 Billion
- **Key Players:** Companies such as Abbott (US), Medtronic(US), Boston Scientific (US), Terumo (JP), Getinge (SE), LivaNova (GB), CardiacAssist (US), ReliantHeart (US), Cleveland Heart (US) are some of the major participants in the global market.

**Report ID:** MRFR/HC/31665-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** June 03, 2026

**URL:** https://www.marketresearchfuture.com/reports/mechanical-circulator-support-device-market-33493

---

## Market Summary

## **Mechanical Circulator Support Device Market Overview**

As per MRFR analysis, the Mechanical Circulator Support Device Market Size was estimated at 3.80 (USD Billion) in 2024. The Mechanical Circulator Support Device Market Industry is expected to grow from 4.10 (USD Billion) in 2025 to 8.19 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 7.97% during the forecast period (2025 - 2034).

### **Key Mechanical Circulator Support Device Market Trends Highlighted**

The Mechanical Circulator Support Device Market is experiencing significant growth driven by factors such as the rising prevalence of heart diseases and the increasing aging population. As the number of patients requiring cardiac support rises, there is a growing demand for advanced circulatory support devices that can provide effective treatment options in critical situations. Additionally, technological advancements in medical devices are enhancing their efficiency and functionality, leading to greater adoption by healthcare providers.

This shift towards better patient outcomes and improved surgical procedures is a key market driver, making mechanical circulatory support devices more appealing in various clinical settings.Numerous opportunities exist for stakeholders to explore within this market. 

Innovations in device design and materials are creating pathways to develop more compact, user-friendly, and biocompatible devices, which can vastly improve patient care. There is also potential for market players to expand their geographic reach, especially in emerging economies where the healthcare infrastructure is evolving. Increased investment in research and development can foster the creation of next-generation devices that deliver enhanced performance and safety, thus capturing a larger share of the market. Recent trends underscore the integration of artificial intelligence and telemedicine with mechanical circulatory support devices, enabling better monitoring and remote patient management.

This technology adoption reflects a broader shift towards personalized medicine, whereby treatments are tailored to individual patient needs, improving overall outcomes. As healthcare systems seek to enhance patient care while managing costs, the demand for innovative circulatory support solutions is likely to rise, further driving growth in the market. The emphasis on minimally invasive procedures and better patient compliance continues to shape the direction of this industry, pointing towards a more efficient and responsive healthcare landscape.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Mechanical Circulator Support Device Market Drivers**

### **Increasing Prevalence of Cardiovascular Diseases**

Cardiovascular diseases (CVDs) are emerging as one of the leading causes of mortality worldwide, significantly driving the growth of the Mechanical Circulator Support Device Market Industry. As the population ages, the incidence of heart-related conditions such as heart failure, coronary artery disease, and other chronic heart diseases continues to rise. The correlation between the aging demographic and cardiovascular ailments necessitates advanced medical interventions, including mechanical circulatory support devices.

These advanced devices play a crucial role in the treatment of patients with severe cardiac dysfunction by improving hemodynamics and enabling better management of heart failure symptoms. Moreover, healthcare providers are increasingly employing these devices as a bridge to heart transplants, promoting their utilization in both acute and chronic heart failure settings.

Continuous innovations in mechanical support technologies are also enhancing patient outcomes, fueling further demand.As the understanding of CVDs expands and new treatment protocols emerge, the Mechanical Circulator Support Device Market Industry is expected to evolve rapidly with expanding opportunities for growth and technological advancements aimed at better patient management.

### **Technological Advancements in Medical Devices**

The Mechanical Circulator Support Device Market Industry is greatly propelled by ongoing technological advancements in the field of medical devices. Innovations such as miniaturization, improved battery life, biocompatible materials, and enhanced monitoring functionalities are leading to significant improvements in device performance and patient experience. These advancements not only enhance the efficacy of circulatory support devices but also promote ease of use and reliability in various clinical settings.Furthermore, the development of next-generation devices capable of providing longer-term support and easier implantation procedures attracts a growing number of healthcare providers and patients seeking effective alternatives for managing severe heart failure.

The continuous investment in research and development underscores the importance placed on technological innovation, ultimately driving the expansion of the market.

### **Growing Awareness and Acceptance of Mechanical Support Devices**

As healthcare providers continue to promote awareness regarding the benefits of mechanical circulatory support devices, patient acceptance and utilization levels are increasing. The Mechanical Circulator Support Device Market Industry benefits from educational initiatives aimed at both healthcare professionals and patients, highlighting the significance and utility of these devices in managing cardiac conditions. Encouraging discussions among cardiologists and healthcare teams regarding treatment options contributes to higher referral rates for device implantation.

## **Mechanical Circulator Support Device Market Segment Insights**

### **Mechanical Circulator Support Device Market Type Insights**

The Mechanical Circulator Support Device Market has shown substantial growth, with several types contributing significantly to this expansion. In 2023, the overall market value was estimated at 3.26 USD Billion, reflecting a robust demand for these medical devices.

Among the various types, the Intra-Aortic Balloon Pump is valued at 0.8 USD Billion in the same year, showcasing its critical role in augmenting coronary perfusion during high-risk surgeries and managing heart failure. With its projected increase to 1.6 USD Billion by 2032, this type plays a crucial role, particularly in emergency and critical care settings, thus asserting its importance in the overall market.The Ventricular Assist Device holds a significant share, valued at 1.5 USD Billion in 2023 and anticipated to expand to 3.0 USD Billion by 2032. 

This device is essential for patients with severe heart failure, allowing them to maintain quality of life while awaiting heart transplants or as a long-term therapy option. Its major growth reflects the increasing prevalence of heart diseases and advancements in technology, enhancing patient outcomes.

Meanwhile, the Total Artificial Heart, with a valuation of 0.4 USD Billion in 2023 and expected to double to 0.8 USD Billion by 2032, plays a vital role, albeit with a smaller market share.This device is primarily utilized in patients with terminal heart failure who are not candidates for transplant, thereby representing a significant but niche segment of the market.

Lastly, Extracorporeal Membrane Oxygenation is valued at 0.56 USD Billion in 2023 and is projected to rise to 1.1 USD Billion by 2032, indicating rising importance in severe cardiac and respiratory failure cases. This method has become vital in critical care units, illustrating a growing trend towards advanced life support technologies. Each type within the Mechanical Circulator Support Device Market segmentation plays a unique role in addressing heart-related health issues, demonstrating both significant current valuations and growth potential, thereby contributing to the overall market landscape.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Mechanical Circulator Support Device Market Application Insights**

The Mechanical Circulator Support Device Market, valued at 3.26 USD Billion in 2023, showcases significant growth potential driven by diverse applications in the healthcare sector. This market is characterized by its wide range of applications, including cardiac surgery, heart failure management, myocardial infarction, and cardiogenic shock, each playing a crucial role in patient care and recovery. Cardiac surgery remains a vital segment, reflecting the demand for advanced support devices during surgical procedures, while heart failure management necessitates innovative solutions to improve patient outcomes.

Myocardial infarction and cardiogenic shock are critical conditions where mechanical support devices provide life-saving assistance, making these applications pivotal for healthcare advancements. The market growth is further fueled by rising incidences of cardiovascular diseases, a growing aging population, and increased investment in medical technology. However, challenges such as high costs and regulatory hurdles could impact market expansion.

Despite this, the ongoing development of more efficient and reliable devices promises ample opportunities within the Mechanical Circulator Support Device Market industry.As a result, the segmentation of applications highlights the diverse needs within the sector, emphasizing the importance of tailored solutions for different critical conditions.

### **Mechanical Circulator Support Device Market End-Use Insights**

The Mechanical Circulator Support Device Market is poised for significant growth, particularly within its End-use segment. Hospitals represent a primary domain for these devices, where critical care and advanced surgeries often necessitate mechanical circulatory support for patients with severe heart conditions. Ambulatory Surgical Centers are also becoming increasingly vital, providing specialized, less invasive procedures that benefit greatly from the efficiency of mechanical support systems. Home Care is emerging as an important area as well, with a rising number of patients seeking recovery and rehabilitation in more comfortable settings outside traditional healthcare facilities.

This trend is driven by the convenience of at-home care and technology advancements, which allow for effective monitoring and support of patients. The overall Mechanical Circulator Support Device Market revenue is expected to be valued at 3.26 billion USD in 2023, emphasizing the significant role that these end-use applications play in driving market growth. Mechanical Circulator Support Device Market data indicates a dynamic landscape where hospitals, ambulatory centers, and home care facilities contribute to the diverse Mechanical Circulator Support Device Market segmentation, reflecting ongoing innovations and a focus on patient-centered care across the Mechanical Circulator Support Device Market industry.

### **Mechanical Circulator Support Device Market Mode of Operation Insights  **

The Mechanical Circulator Support Device Market is expanding steadily, with a valuation of 3.26 USD billion in 2023 and projected growth to 6.5 USD billion by 2032. Within the mode of operation segment, the market encompasses both implantable devices and extracorporeal devices, each playing a critical role in patient care. [Implantable port](../../../reports/implantable-port-market-37190) have become a cornerstone of therapy for patients requiring long-term support, fostering improved patient outcomes and encouraging greater investment in research and development. 

Meanwhile, extracorporeal devices dominate in acute settings, offering rapid deployment and effective support for patients in critical care.The ongoing innovation within these categories continues to create new opportunities, enabling better management of heart dysfunctions while addressing the complexities involved in device implantation and patient monitoring. As healthcare providers seek to optimize treatment protocols, the Mechanical Circulator Support Device Market is poised to experience significant advancements alongside rising healthcare demand and evolving patient needs.

### **Mechanical Circulator Support Device Market Regional Insights  **

The Mechanical Circulator Support Device Market is experiencing significant growth, with North America leading the charge, holding a valuation of 1.224 USD Billion in 2023, reflecting its dominant position due to advanced healthcare infrastructure and high patient demand. Europe follows closely, valued at 0.765 USD Billion, supported by strong healthcare investments and technological advancements. The APAC region, while currently at 0.612 USD Billion, is poised for notable expansion, driven by rising healthcare access and increasing awareness of cardiac therapies.

South America, with a valuation of 0.306 USD Billion, presents growth opportunities through improvements in medical technologies and an expanding patient base. Meanwhile, the MEA region, valued at 0.352 USD Billion, is emerging gradually, with a focus on enhancing healthcare services. Each of these regions contributes to the Mechanical Circulator Support Device Market revenue, showcasing diverse growth dynamics and opportunities across different economies. The majority holding in North America underscores its significance in setting industry standards and innovations, while the emerging markets in APAC and MEA signify the potential for future expansion in the Mechanical Circulator Support Device Market statistics.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Mechanical Circulator Support Device Market Key Players and Competitive Insights**

Competitive insights reveal a landscape where not only established players hold significant market shares but also emerging companies are making their mark with innovative solutions. Strategic collaborations, mergers and acquisitions, as well as ongoing research and development activities, are essential to enhance product portfolios and expand market reach. Companies are focusing on regulatory approvals and building a strong distribution network to cater to the changing needs of healthcare providers and patients.

This competitive environment fosters a dynamic atmosphere where technological advancements are pivotal in shaping the future of mechanical circulator support devices.Cleveland Heart stands out within the Mechanical Circulator Support Device Market due to its commitment to innovation and quality in developing heart support technologies. 

The company has a strong reputation for producing devices that provide reliable and effective support to patients suffering from severe cardiac conditions. Their solutions are tailored towards enhancing surgical outcomes, thus ensuring improved patient recovery timelines. Cleveland Heart's continuous investment in research and development has resulted in cutting-edge devices that are not only clinically relevant but also aligned with the latest healthcare trends. Moreover, their established relationships with healthcare consumers and providers facilitate a robust distribution network, giving them a significant advantage in the marketplace.

The company's commitment to safety and efficacy in its product offerings reinforces its market position and fosters trust among healthcare professionals.

Boston Scientific has established a firm footing in the Mechanical Circulator Support Device Market through its strategic approach to developing advanced medical technologies aimed at treating cardiovascular diseases. The company is recognized for its extensive product range that includes various mechanical circulatory support devices designed to improve patient outcomes. Boston Scientific emphasizes innovation through rigorous research initiatives, resulting in state-of-the-art solutions that not only meet regulatory standards but also address the evolving needs of clinicians and patients. Its well-structured marketing and distribution strategies enable Boston Scientific to maintain a competitive edge by reaching diverse geographical markets. 

The company's focus on collaboration with healthcare professionals ensures that its products are both clinically relevant and practical, thereby driving adoption rates and enhancing its influence in the mechanical circulatory support landscape.

### **Key Companies in the Mechanical Circulator Support Device Market Include**

- Cleveland Heart
- [Boston Scientific](https://www.bostonscientific.com/en-IN/medical-specialties/electrophysiology/products.html)
- Tandem Diabetes
- HeartWare International
- Medtronic
- Abbott Laboratories
- Getinge AB
- Terumo Corporation
- NeuroTrac
- Fresenius SE and  KGaA
- Nordion
- Jude Medical
- Abiomed
- SynCardia Systems
- CardioGenics

## Mechanical Circulator Support Device Industry Developments

- **Q2 2024: CorWave receives CE Mark approval for its left ventricular assist device** CorWave announced it has received CE Mark approval for its left ventricular assist device, enabling commercial launch in the European Union.
- **Q2 2024: Abiomed launches Impella ECP, the world’s smallest heart pump, in Europe** Abiomed announced the commercial launch of its Impella ECP, a next-generation expandable heart pump, in select European markets following regulatory clearance.
- **Q1 2024: BiVACOR secures $18 million Series B funding to advance artificial heart development** BiVACOR raised $18 million in Series B funding to support clinical trials and further development of its total artificial heart technology.
- **Q2 2024: Medtronic receives FDA approval for HeartWare HVAD System for destination therapy** Medtronic announced FDA approval for its HeartWare HVAD System as a destination therapy for patients with advanced heart failure.
- **Q1 2025: Procyrion raises $30 million Series C to expand mechanical circulatory support device trials** Procyrion closed a $30 million Series C funding round to accelerate clinical trials and commercialization of its mechanical circulatory support device.
- **Q2 2025: Abbott announces partnership with Cleveland Clinic to advance cardiac support device research** Abbott entered a strategic partnership with Cleveland Clinic to collaborate on research and development of next-generation mechanical circulatory support devices.
- **Q2 2024: FDA grants Breakthrough Device designation to Evaheart’s next-generation ventricular assist device** Evaheart received Breakthrough Device designation from the FDA for its new ventricular assist device, expediting regulatory review and development.
- **Q3 2024: Windmill Cardiovascular Systems opens new manufacturing facility in Texas** Windmill Cardiovascular Systems inaugurated a new manufacturing facility in Texas to scale up production of its mechanical circulatory support devices.
- **Q1 2025: SynCardia Systems appoints new CEO to lead global expansion** SynCardia Systems announced the appointment of a new CEO to drive international growth and commercialization of its total artificial heart products.
- **Q2 2025: NuPulseCV receives FDA IDE approval for clinical trial of intravascular ventricular assist system** NuPulseCV received FDA Investigational Device Exemption (IDE) approval to begin clinical trials of its intravascular ventricular assist system in the United States.
- **Q1 2024: Abbott launches new HeartMate 3 LVAD in Japan following regulatory approval** Abbott announced the launch of its HeartMate 3 left ventricular assist device in Japan after receiving regulatory approval from Japanese authorities.
- **Q3 2024: Evaheart partners with Mayo Clinic for clinical research on advanced heart failure therapies** Evaheart entered a partnership with Mayo Clinic to conduct clinical research on its mechanical circulatory support devices for advanced heart failure patients.

## **Mechanical Circulator Support Device Market Segmentation Insights**

### **Mechanical Circulator Support Device Market Type Outlook**

- Intra-Aortic Balloon Pump
- Ventricular Assist Device
- Total Artificial Heart
- Extracorporeal Membrane Oxygenation

### **Mechanical Circulator Support Device Market Application Outlook**

- Cardiac Surgery
- Heart Failure Management
- Myocardial Infarction
- Cardiogenic Shock

### **Mechanical Circulator Support Device Market End-Use Outlook**

- Hospitals
- Ambulatory Surgical Centers
- Home Care

### **Mechanical Circulator Support Device Market Mode of Operation Outlook**

- Implantable Devices
- Extracorporeal Devices

### **Mechanical Circulator Support Device Market Regional Outlook**

- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa

## Market Drivers

### Technological Innovations in Device Design

技术进步在塑造机械循环器支撑设备行业方面发挥着关键作用。小型化、增强的生物相容性和延长的电池寿命等创新正在改变设备功能和患者体验。最近的发展导致了不仅效率更高而且更易于植入和管理的设备的引入。
 
例如，无线技术的集成可以实现远程监控，从而提高患者的安全性和依从性。随着这些技术的发展，预计将吸引更多的医疗保健提供者采用机械循环支持设备，从而扩大全球市场。对研发的持续投资可能会带来进一步的突破，巩固市场在医疗保健领域的地位。
 

- IHME 数据强调，心血管疾病是导致残疾调整生命年的全球主要原因，每年造成超过 4 亿人的伤残调整生命年 (DALY)。这种日益严重的疾病负担正在加速机械循环支持设备的创新，鼓励开发小型化、生物相容性系统，以提高晚期心力衰竭患者的生存率并减少并发症。

### Rising Incidence of Cardiovascular Diseases

心血管疾病的患病率持续上升，推动了对先进治疗方案的需求。机械循环支持设备行业对能够帮助患有严重心脏病的患者的设备的需求激增。
 
根据最新数据，心血管疾病占全球死亡率的很大一部分，因此需要创新的解决方案。随着医疗保健提供者寻求改善患者的治疗效果，机械循环支持设备的采用可能会增加。人口老龄化进一步支持了这一趋势，人口老龄化更容易患心脏病。因此，全球市场有望实现增长，因为它满足了对心血管护理有效干预措施的迫切需求。
 

- 世界银行的健康指标显示，心血管疾病每年导致全世界约 1700 万人以上死亡，而且在老龄化人口中患病率不断上升。随着医疗保健系统投资先进的心脏护理技术来管理严重心力衰竭并改善患者的生存结果，这种不断上升的疾病发病率极大地推动了对机械循环支持设备的需求。

### Regulatory Support and Reimbursement Policies

监管支持和有利的报销政策是全球市场的重要驱动力。政府和监管机构越来越认识到机械循环支持装置在改善患者治疗效果方面的重要性。因此，简化新设备审批流程的趋势日益明显，这可能会鼓励制造商创新并将新产品推向市场。
 
此外，有利的报销政策可以显着影响这些设备的采用率，因为医疗保健提供者更有可能投资于有财政支持的技术。这种监管环境可能会为机械循环支持设备行业的发展营造更有利的氛围，最终使需要高级心脏支持的患者受益。
 

- PubMed 索引的临床研究表明，有利的报销框架可以将高级心脏护理机构中的设备采用率提高 30-40%。机械循环支持设备的监管批准加快了治疗的可及性，鼓励医院整合创新的心脏辅助技术并改善急性和慢性心力衰竭患者的生存结果。

### Increasing Investment in Healthcare Infrastructure

医疗基础设施投资是影响机械循环支持设备行业的关键因素。政府和私营实体正在分配大量资源来加强医疗保健设施，特别是在心血管疾病高发地区。这项投资可能会促进先进医疗技术的获取，包括机械循环支持设备。
 
增强的基础设施不仅可以改善获得护理的机会，还可以支持医疗保健专业人员使用这些设备的培训。随着医院和诊所的设施升级，对患者管理创新解决方案的需求预计将会增加。因此，随着越来越多的医疗保健提供商寻求实施尖端技术，全球市场将从这一趋势中受益。
 

- 世界银行数据显示，全球高收入国家医疗保健支出超过 GDP 的 10%，支持了先进心脏护理基础设施的发展。这项投资使医院能够采用机械循环支持设备，提高重症监护能力，扩大手术设施，并提高需要挽救生命的循环辅助技术的心血管疾病患者的治疗可及性。

### Growing Awareness and Education Among Healthcare Professionals

医疗保健专业人员对机械循环支持装置的认识和教育不断提高，是机械循环支持装置行业的重要驱动力。随着医疗培训计划融入先进技术和治疗方式，从业者越来越了解这些设备的好处和应用。
 
这种意识的提高可能会导致在患者护理方面做出更明智的决策。此外，专业组织正在积极推广使用机械循环支持的指南和最佳实践，这可能会提高这些设备的采用率。随着医疗保健专业人员越来越善于利用这些技术，预计市场将对增长产生积极影响。
 

- IHME 报告显示，全球心血管培训项目不断增加，每年有超过 150 万医疗保健专业人员接受高级心脏护理教育。这种不断提高的认识正在改善机械循环支持设备的采用，从而实现更好的临床决策，增强患者管理策略，并改善严重心力衰竭治疗途径的生存结果。

## Future Outlook

机械循环支持装置市场预计将在2024年至2035年间以7.97%的年均增长率增长，推动因素包括技术进步、心脏疾病的日益普遍以及医疗支出的增加。

**New opportunities:**

- 为居家护理环境开发便携式循环支持设备。 将人工智能集成用于设备性能的预测分析。 通过量身定制的融资解决方案扩展到新兴市场。

到2035年，市场预计将实现显著增长，定位为心血管支持技术的领导者。

## Segment Insights

### 按类型：心室辅助装置（最大）与主动脉内球囊反搏器（增长最快）

在机械循环支持设备市场中，心室辅助设备 (VAD) 占据最大的 46% 市场份额，这得益于其在晚期心力衰竭患者中的​​广泛临床应用。相比之下，主动脉内球囊反搏泵 (IABP) 已成为增长最快的细分市场，其推动因素是急诊护理环境需求的增加以及技术进步导致患者治疗效果的改善。增长趋势表明，VAD 的采用量强劲增长，因为它们成为管理严重心脏病的核心，尤其是在过渡护理场景中。 IABP 的快速增长可归因于其在各种心脏手术中的功效，以及医疗保健提供者采用创新支持设备以实现更好的术后恢复的趋势不断上升，这有助于其市场渗透率的不断提高。

Abbott 的心室辅助创新（包括下一代心脏泵系统）已支持 500 多项以患者为中心的临床评估，提高了晚期心力衰竭病例的长期生存率。该公司持续的研发投资提高了 VAD 效率，巩固了其在机械循环支持技术方面的主导地位，并扩大了全球心脏治疗中心的采用。

### 按应用分类：心力衰竭管理（最大）与心源性休克（增长最快）

在机械循环支持设备市场中，应用领域非常多样化，包括心脏手术、心力衰竭管理、心肌梗死和心源性休克等领域。其中，心力衰竭管理占据了领先的 39% 市场份额，反映了其在现代医疗保健实践中的重要意义。与此同时，心源性休克正在成为一个重要的参与者，吸引了新的创新和技术投资。这些应用对高级支持设备的稳定需求在各自的市场分布中显而易见。市场内的增长趋势表明，心力衰竭管理设备的采用显着增加，这主要是由于心脏相关疾病的发病率上升所致。心肌梗塞和心源性休克等细分市场价值也受益于增强的紧急护理方案和技术进步。对心脏病预防解决方案和有效管理的整体推动继续巩固市场格局，促进各种应用的大幅增长。

美敦力通过每年在全球数千例植入手术中使用的先进循环支持系统，加强了心力衰竭管理解决方案，改善了患者的生存结果。扩大心脏适应症的监管批准使得其得到更广泛的采用，而临床进展则继续提高全球慢性和急性心力衰竭管理的治疗效率。

### 按最终用途：医院（最大）与门诊手术中心（增长最快）

在机械循环支持设备市场中，医院代表了主导的最终用途领域，占据了领先的 51% 市场份额。它们在采用和部署先进医疗技术（包括循环支持设备）方面发挥着关键作用。这些设施配备了必要的基础设施和熟练的人员来运营复杂的设施[医疗器械](https://www.marketresearchfuture.com/reports/medical-devices-market-2869)并提供全面的患者护理。相比之下，由于对门诊手术的偏好不断增加以及对微创手术的需求不断增长，门诊手术中心正在快速增长。随着治疗模式的转变，这些中心正在成为提供循环支持护理的重要参与者，利用其减少患者康复时间和成本的能力。机械循环支持装置市场的增长趋势受到技术进步和心血管疾病患病率上升的显着影响。医院不断通过创新的循环设备扩展其能力，从而改善患者的治疗效果。与此同时，门诊手术中心正在采用这些技术来增强其服务，进一步促进其发展。随着医疗保健法规的发展和患者偏好转向微创治疗，这两个细分市场都可能会经历重大变化，从而形成优先考虑高质量护理和运营效率的竞争格局。

波士顿科学公司通过在全球 600 多家三级护理医院部署的先进心脏护理技术，支持医院采用循环支持系统。增强的设备可靠性和临床支持计划提高了重症监护效率，增强了医院处理严重心脏病病例的能力，并增加了机械循环支持设备的采用。

### 按操作模式：植入设备（最大）与体外设备（增长最快）

在机械循环支持设备市场中，植入式设备在操作方式领域占据主导地位，因其有效性和长期可用性而受到需要循环支持的患者的青睐。他们占据了 44% 的市场份额，这得益于他们在为慢性心力衰竭病例提供必要支持方面的良好地位和经过验证的临床成功。相反，体外设备正在迅速兴起，因其在各种临床环境中的多功能性和适应性而受到关注，特别是在手术或急性心脏病期间，占据了越来越大的市场份额。

Terumo 的植入式循环支持技术帮助改善了 400 多个临床心脏中心的治疗结果，增强了心力衰竭病例的长期患者管理。持续的产品创新和生物相容性材料的进步正在提高植入的成功率，支持全球范围内更广泛的临床采用植入式机械循环支持系统。

## Regional Market Share Analysis

### 北美：领先的创新和采用

北美是机械循环器支撑装置的最大市场，约占全球市场份额的45%。该地区受益于先进的医疗基础设施、心血管疾病的高患病率以及对医疗技术的大量投资。 FDA 等机构的监管支持进一步加速了这些设备的创新和采用，推动了市场增长。

美国是主要贡献者，雅培、美敦力和波士顿科学等主要参与者在竞争格局中处于领先地位。成熟的医疗保健系统的存在以及对研发的关注为机械循环器支持设备营造了一个强大的环境。加拿大也发挥着重要作用，通过不断增长的医疗保健投资为整体市场动态做出了贡献。

- 北美由于先进的心脏基础设施和高疾病患病率而占据主导地位。 CDC 报告称，美国每年约有 805,000 例心脏病发作，这极大地推动了对机械循环支持设备的需求。克利夫兰心脏计划强调通过先进的心脏辅助技术改善生存结果，加强区域市场领导地位。

### 欧洲：监管框架和增长

2024年欧洲市场占30%份额，创收约11.4亿美元。该地区的增长是由人口老龄化、心脏病患病率增加以及支持性监管框架推动的。欧洲药品管理局 (EMA) 在确保这些设备的安全性和有效性方面发挥着至关重要的作用，这增强了市场信心并鼓励创新。

欧洲的主要国家包括德国、法国和英国，这些国家在医疗保健方面进行了大量投资。竞争格局中包括 Getinge 和 LivaNova 等积极参与研发的主要参与者。先进医疗保健系统的存在以及对改善患者治疗结果的关注进一步提振了机械循环器支持设备的市场。

- 欧洲在 EMA 监管框架的支持下表现出强劲的采用率，确保设备安全和创新。 EMA 每年评估 100 多种高风险医疗器械申请，其中包括心脏辅助技术。这种监管效率加快了审批周期，从而能够更快地获得机械循环支持设备并改善整个欧洲的心血管患者护理结果。

### 亚太地区：快速增长和新兴市场

亚太地区市场增长迅速，约占全球份额的20%。医疗支出的增加、心血管疾病意识的提高以及医疗基础设施的改善推动了该地区的扩张。受其庞大的人口数量和对先进医疗技术不断增长的需求的推动，中国和印度等国家正在成为主要市场。

中国在亚太地区市场处于领先地位，在医疗保健领域进行了大量投资并注重创新。竞争格局包括本地和国际参与者，例如 Terumo 和 ReliantHeart。该地区多样化的医疗保健需求和监管挑战为市场参与者带来了机遇和障碍，使其成为机械循环器支持设备的动态环境。

### 中东和非洲：尚未开发的潜力和挑战

中东和非洲地区市场逐渐崛起，占据全球约5%的份额。这一增长是由医疗保健投资增加、心血管疾病患病率上升以及对先进医疗技术日益增长的兴趣推动的。然而，各国的监管挑战和不同的医疗保健标准对市场渗透构成了重大障碍。

在政府改善医疗基础设施举措的支持下，南非和阿联酋等国家在采用先进医疗设备方面处于领先地位。竞争格局仍在发展，本地和国际参与者都有机会站稳脚跟。随着心血管健康意识的增强，该地区对机械循环器支持装置的需求预计将会上升。

## Competitive Benchmarking

机械循环器支持设备市场的特点是在技术进步和心血管疾病患病率不断上升的推动下，竞争格局充满活力。雅培（美国）、美敦力（美国）和波士顿科学（美国）等主要参与者处于领先地位，各自采取独特的策略来增强其市场地位。雅培（美国）专注于通过开发下一代设备进行创新，而美敦力（美国）则强调战略合作伙伴关系以扩大其产品范围。
 
波士顿科学公司（美国）正在积极进行并购以增强其产品组合，这表明市场出现了整合的趋势。总的来说，这些战略有助于形成越来越以技术创新和战略合作为中心的竞争环境。在商业策略方面，企业正在本地化制造以降低成本并优化供应链，这在全球供应链中断的背景下尤其重要。
 
市场结构显得较为分散，多家参与者争夺市场份额。然而，大公司的影响力是巨大的，因为它们设定了创新和卓越运营的步伐，从而塑造了整体市场动态。
 
8 月，雅培（美国）宣布推出最新的机械循环支持设备，该设备集成了先进的人工智能算法，以增强患者监测和结果。这一战略举措不仅凸显了雅培对创新的承诺，而且使该公司能够利用人工智能技术来改善设备功能和患者护理。这些进步可能会在行业中树立新的基准，迫使竞争对手加快自己的创新努力。
 
九月，美敦力（美国）与一家领先的远程医疗提供商建立了战略合作伙伴关系，以增强其循环支持设备的远程患者监测能力。这种合作表明了数字健康解决方案的更广泛趋势，数字健康解决方案在管理慢性病方面变得越来越重要。通过整合远程医疗服务，美敦力旨在提高患者的参与度和依从性，从而有可能带来更好的健康结果并减少再入院率。
 
7 月，波士顿科学公司（美国）完成了对一家专门从事下一代循环支持技术的小型公司的收购。此次收购具有战略意义，不仅扩大了波士顿科学公司的产品组合，还增强了其研发能力。收购公司的创新技术的整合预计将加速先进循环支持解决方案的开发，从而加强波士顿科学公司在全球市场的竞争地位。
 
截至十月，全球行业正在见证数字化、可持续发展和人工智能集成等趋势。这些趋势正在重塑竞争格局，企业越来越多地结成战略联盟，以增强其技术能力和市场覆盖范围。时间
 
随着公司认识到供应链可靠性和先进解决方案对于保持竞争优势的重要性，从基于价格的竞争转向注重创新和技术的转变是显而易见的。展望未来，该市场的差异化可能取决于创新和适应新兴技术的能力，确保公司能够不断响应医疗保健提供者和患者不断变化的需求。

## Recent News & Developments

- **2024年第二季度：CorWave获得其左心室辅助装置的CE标志批准** CorWave宣布已获得其左心室辅助装置的CE标志批准，允许在欧盟进行商业发布。
- **2024年第二季度：Abiomed在欧洲推出全球最小的心脏泵Impella ECP** Abiomed宣布在获得监管许可后，在部分欧洲市场商业推出其下一代可扩展心脏泵Impella ECP。
- **2024年第一季度：BiVACOR获得1800万美元B轮融资以推进人工心脏开发** BiVACOR筹集了1800万美元的B轮融资，以支持其全人工心脏技术的临床试验和进一步开发。
- **2024年第二季度：美敦力获得FDA批准将HeartWare HVAD系统用于目的治疗** 美敦力宣布其HeartWare HVAD系统获得FDA批准，作为晚期心力衰竭患者的目的治疗。
- **2025年第一季度：Procyrion筹集3000万美元C轮融资以扩展机械循环支持装置试验** Procyrion完成了3000万美元的C轮融资，以加速其机械循环支持装置的临床试验和商业化。
- **2025年第二季度：雅培宣布与克利夫兰诊所建立合作关系以推进心脏支持装置研究** 雅培与克利夫兰诊所建立战略合作关系，共同研究和开发下一代机械循环支持装置。
- **2024年第二季度：FDA授予Evaheart下一代心室辅助装置突破性设备认证** Evaheart获得FDA授予的突破性设备认证，以加快其新型心室辅助装置的监管审查和开发。
- **2024年第三季度：Windmill心血管系统在德克萨斯州开设新制造设施** Windmill心血管系统在德克萨斯州启用了新制造设施，以扩大其机械循环支持装置的生产。
- **2025年第一季度：SynCardia系统任命新首席执行官以推动全球扩张** SynCardia系统宣布任命新首席执行官，以推动其全人工心脏产品的国际增长和商业化。
- **2025年第二季度：NuPulseCV获得FDA IDE批准以进行血管内心室辅助系统的临床试验** NuPulseCV获得FDA的研究性设备豁免（IDE）批准，以在美国开始其血管内心室辅助系统的临床试验。
- **2024年第一季度：雅培在日本推出新的HeartMate 3 LVAD，获得监管批准** 雅培宣布在获得日本当局的监管批准后，在日本推出其HeartMate 3左心室辅助装置。
- **2024年第三季度：Evaheart与梅奥诊所合作进行先进心力衰竭疗法的临床研究** Evaheart与梅奥诊所建立合作关系，进行其机械循环支持装置在先进心力衰竭患者中的临床研究。

## Report Scope

| 2024年市场规模 | 3.801（十亿美元） |
| --- | --- |
| 2025年市场规模 | 4.104（十亿美元） |
| 2035年市场规模 | 8.838（十亿美元） |
| 年复合增长率（CAGR） | 7.97%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 生物相容材料的进步提升了机械循环支持设备市场的性能。 |
| 主要市场动态 | 技术进步和监管变化推动机械循环支持设备市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 2035年机械循环支持设备市场的预计市场估值是多少？**
A: 预计到2035年，机械循环支持装置市场的市场估值为88.38亿美元。

**Q: 2024年机械循环支持装置市场的市场估值是多少？**
A: 2024年机械循环支持装置市场的市场估值为38.01亿美元。

**Q: 2025年至2035年机械循环支持设备市场的预期CAGR是多少？**
A: 机械循环支持装置市场在2025年至2035年预测期内的预期CAGR为7.97%。

**Q: 在机械循环支持装置市场中，哪些公司被视为关键参与者？**
A: 机械循环支持装置市场的主要参与者包括雅培、美敦力、波士顿科学、泰尔茂、基因科技、利瓦诺瓦、心脏辅助、可靠心脏和克利夫兰心脏。

**Q: 到2035年，主动脉内球囊泵细分市场的预计值是多少？**
A: 预计到2035年，主动脉内球囊泵细分市场的价值将达到18亿美元。

**Q: 心室辅助装置细分市场在市场估值方面表现如何？**
A: 心室辅助装置细分市场预计将从2024年的12亿美元增长到2035年的30亿美元。

**Q: 到2035年，体外膜氧合（ECMO）细分市场的预期市场规模是多少？**
A: 预计到2035年，体外膜氧合（ECMO）细分市场的预期市场规模将达到28.38亿美元。

**Q: 心力衰竭管理应用程序细分市场的预计增长是多少？**
A: 心力衰竭管理应用程序细分市场预计将从2024年的11.405亿美元增长到2035年的26.1亿美元。

**Q: 到2035年，医院作为最终使用细分市场的预期市场规模是多少？**
A: 预计到2035年，医院作为最终使用细分市场的预期市场规模将达到35亿美元。

**Q: 到2035年，体外设备操作模式细分市场的预计值是多少？**
A: 预计到2035年，体外设备操作模式细分市场的预计价值将达到62.275亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/mechanical-circulator-support-device-market-33493*